Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUTCHMED

24.200
+0.4401.85%
Volume:7.28M
Turnover:175.40M
Market Cap:21.10B
PE:70.60
High:24.400
Open:23.800
Low:23.720
Close:23.760
52wk High:30.750
52wk Low:18.360
Shares:872.00M
HK Float Shares:872.00M
Volume Ratio:1.55
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.343
ROE:46.90%
ROA:-0.81%
PB:2.21
PE(LYR):70.60
PS:4.51

Loading ...

Company Profile

Company Name:
HUTCHMED
Exchange:
SEHK
Establishment Date:
2000
Employees:
1780
Office Location:
Cheung Kong Center,48th floor,2 Queen's Road Central,Hong Kong,Hong Kong
Zip Code:
- -
Fax:
852 2128 1778
Introduction:
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Directors

Name
Position
Dan ELDAR
Chairman of the Board,Director,Member of the Nomination Committee,Member of Other Special Committees of the Board of Directors
ZHENG Ze Feng
Executive Director,Member of Other Special Committees of the Board of Directors
Weiguo SU
Executive Director,Member of Other Special Committees of the Board of Directors
MO Shu Jin
Independent Director,Independent Director,Chairman of the Nomination Committee,Chairman of Other Special Committees of the Board of Directors,Member of Other Special Committees of the Board of Directors
Renu BHATIA
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member,Member of Other Special Committees of the Board of Directors
Chaohong HU
Independent Director,Member of the Nomination Committee,Audit Committee Member,Member of Other Special Committees of the Board of Directors
WONG Tak Wai
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
CHEN Shao Wen
Independent Director,Member of Other Special Committees of the Board of Directors
SHIH Edith
Director,Member of the Remuneration and Assessment Committee,Chairman of Other Special Committees of the Board of Directors
YANG Ling
Director

Shareholders

Name
Position
ZHENG Ze Feng
Acting CEO,CFO
Weiguo SU
CEO,Chief Science Officer
May Wang
Vice General Manager,Other Senior Executives
Mark Lee
Vice General Manager
SHIH Edith
Corporate Secretary
Zhenping WU
Other Senior Executives
SHI Ming
Other Senior Executives,Other Senior Executives,Other Senior Executives
Charles George Rupert NIXON
Advisor